
doi: 10.1136/bmj.i1757
pmid: 27075170
Part research project, part commercial stimulus, this enormous sequencing programme could usher genomic medicine into mainstream use, Mark Peplow reports
Genetic Research, Rare Diseases, Genome, Human, Neoplasms, Humans, Genomics, Sequence Analysis, DNA, Confidentiality
Genetic Research, Rare Diseases, Genome, Human, Neoplasms, Humans, Genomics, Sequence Analysis, DNA, Confidentiality
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 63 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
